{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:57:52Z","timestamp":1761490672646},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"vor","delay-in-days":263,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.ebcr.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T06:21:18Z","timestamp":1539066078000},"page":"133-136","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Valproic acid as a monotherapy in drug-resistant methyl-CpG-binding protein 2 gene (MECP2) duplication-related epilepsy"],"prefix":"10.1016","volume":"10","author":[{"given":"Meghna","family":"Rajaprakash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Richer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Sell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebcr.2018.09.009_bb0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ejhg.2008.208","article-title":"Structural variation in Xq28: MECP2 duplication in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy","volume":"17","author":"Lugtenberg","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/444549","article-title":"Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males","volume":"77","author":"Van Esch","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.ebcr.2018.09.009_bb0015","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1542\/peds.2006-0395","article-title":"Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28","volume":"118","author":"Friez","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejpn.2014.03.005","article-title":"Late onset epileptic spasms is frequent in MECP2 gene duplication: electroclinical features and long-term follow-up of 8 epilepsy patients","author":"Caumes","year":"2014","journal-title":"Eur J Pediatr Neurol"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0025","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/jmg.2004.023804","article-title":"Submicroscopic duplications in Xq28 causes increased expression of the MECP2 gene in a boy with severe retardation and features of Rett syndrome","volume":"42","author":"Meins","year":"2005","journal-title":"J Med Genet"},{"issue":"7","key":"10.1016\/j.ebcr.2018.09.009_bb0030","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1528-1167.2012.03501.x","article-title":"Electroclinical pattern in MECP2 duplication syndrome: eight new reported cases and review of literature","volume":"53","author":"Vignoli","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ebcr.2018.09.009_bb0035","first-page":"17","article-title":"Pharmacology of valproate","volume":"37","author":"Owens","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0040","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ajmg.a.36373","article-title":"Clinical characterization and identification of duplication breakpoints in a Japanese family with Xq28 duplication syndrome including MECP2","volume":"164A","author":"Fukushi","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ejhg.2008.192","article-title":"Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance","volume":"17","author":"Clayton-Smith","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"10.1016\/j.ebcr.2018.09.009_bb0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14656566.2017.1328499","article-title":"Anticonvulsant drugs for generalized tonic\u2013clonic epilepsy","volume":"18","author":"Coppola","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0920-1211(96)01007-8","article-title":"Lamotrigine substitution study: evidence for synergism with sodium valproate?","volume":"26","author":"Brodie","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.seizure.2017.08.001","article-title":"Lamotrigine versus valproic acid monotherapy for generalised epilepsy: a meta-analysis of comparative studies","volume":"51","author":"Tang","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.ebcr.2018.09.009_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000074668","article-title":"Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?","volume":"70","author":"Lackmann","year":"2004","journal-title":"Pharmacology"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323218300987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323218300987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T18:18:06Z","timestamp":1542651486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323218300987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":13,"alternative-id":["S2213323218300987"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2018.09.009","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid as a monotherapy in drug-resistant methyl-CpG-binding protein 2 gene (MECP2) duplication-related epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}